Ödenen temettü · 2025 mali yılı
| 1 | AbbVieABBV | $11,7B |
|---|---|---|
| 2 | MerckMRK | $8,2B |
| 3 | UnitedHealth GroupUNH | $7,9B |
| 4 | Novo Nordisk A SNVO | $7,8B |
| 5 | Eli LillyLLY | $5,4B |
| 6 | AmgenAMGN | $5,1B |
| 7 | Bristol Myers SquibbBMY | $5,0B |
| 8 | AstraZenecaAZN | $5,0B |
| 9 | Abbott LaboratoriesABT | $4,1B |
| 10 | Gilead SciencesGILD | $4,0B |